Everence Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Everence Capital Management’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12,650	Closed	-$119	–	815
2023 Q3	$119	Hold	12,650	–	–	0.01%	731
2023 Q2	$195K	Hold	12,650	–	–	0.02%	659
2023 Q1	$237	Hold	12,650	–	–	0.02%	623
2022 Q4	$174	Buy	+12,650	New	+$194K	0.02%	717
2022 Q3	–	Sell	-13,350	Closed	-$204K	–	750
2022 Q2	$204K	Hold	13,350	–	–	0.02%	639
2022 Q1	$272K	Hold	13,350	–	–	0.02%	588
2021 Q4	$390K	Buy	+13,350	New	+$382K	0.03%	506

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Everence Capital Management's CDMO Position: Q4 2023 in Review

Everence Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2023, closing a stake of 12,650 shares — an estimated $119 sold.

Everence Capital Management first reported a position in CDMO in Q4 2021 and held it in 7 quarters. The position peaked at $390K in Q4 2021. 174 funds tracked by Wall St. Rank hold CDMO as of Q4 2023.

Everence Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Everence Capital Management sold 12,650 Avid Bioservices, Inc. Common Stock shares in Q4 2023, an estimated $119.
Everence Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Everence Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $390K in Q4 2021.
174 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2023.

Based on Everence Capital Management's 13F filing for Q4 2023, filed 30 Jan 2024.